Literature DB >> 6271450

Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture.

G Murphy, M B McGuire, R G Russell, J J Reynolds.   

Abstract

1. Explants of human synovium from normal, rheumatoid and osteoarthritic subjects produced proteinases in culture that could degrade connective tissue macromolecules at neutral pH. 2. The proteinases detected in the media were predominantly of the class requiring metal ions for activity, and occurred in either partially or wholly latent forms. Activation could be achieved by treatment with either trypsin or the organo-mercurial, 4-aminophenylmercuric acetate. 3. Explants of both normal and osteoarthritic synovium produced an inhibitor of collagenase in the early days of culture, similar to that previously described for rabbit tissues. In contrast, no free inhibitor could be detected in the media of rheumatoid synovial cultures. 4. Explants of normal human articular cartilage produced latent collagenase and free inhibitor in culture. 5. These findings suggest that the activity of tissue-derived metallo-proteinases may be controlled by locally synthesized inhibitors, by mechanisms analogous to those already described for rabbit model systems. Changes in the synthesis and degradation of inhibitor could be important in human diseases in which destruction of connective tissue is a prominent feature.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271450     DOI: 10.1042/cs0610711

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

1.  TIMP-2 is required for efficient activation of proMMP-2 in vivo.

Authors:  Z Wang; R Juttermann; P D Soloway
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

2.  Procollagenase activator produced by rabbit uterine cervical fibroblasts.

Authors:  M Ishibashi; A Ito; K Sakyo; Y Mori
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

3.  Properties of rheumatoid and normal synovial tissue in vitro and cells derived from them. Production of prostaglandins and collagenase in response to factors derived from cultured blood mononuclear cells and from synovium.

Authors:  M K McGuire; J E Meats; N M Ebsworth; L Harvey; G Murphy; R G Russell; J J Reynolds
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

4.  Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. I. Quantitative histopathology; PMN, basophil, and mononuclear cell survival; and unbound (serum) protein content.

Authors:  A M Dannenberg; P J Pula; L H Liu; S Harada; F Tanaka; R F Vogt; A Kajiki; K Higuchi
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

5.  Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases.

Authors:  D D Dean; J F Woessner
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  The cartilage-resorbing protein catabolin is made by synovial fibroblasts and its production is increased by phorbol myristate acetate.

Authors:  L M Pilsworth; J Saklatvala
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

Review 7.  Recent contributions to knowledge of the mechanism of action of nimesulide.

Authors:  M Bevilacqua; E Magni
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Neutral protease, collagenase and elastase activities in synovial fluids from arthritic patients.

Authors:  N Al-Haik; D A Lewis; G Struthers
Journal:  Agents Actions       Date:  1984-10

9.  Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage.

Authors:  R M Hembry; M R Bagga; G Murphy; B Henderson; J J Reynolds
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage.

Authors:  Q Nguyen; J S Mort; P J Roughley
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.